Therapeutic regimens and prognostic factors of brain metastatic cancers

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 2, 2013, Pages 923-927

  Song, Wen Guang ^a   Wang, Yi Feng ^a   Wang, Rui Lin ^a   Qu, Yin e ^b   Zhang, Zhi ^a   Li, Guo Zhong ^a   Xiao, Ying ^a   Fang, Fang ^a   Chen, Hong ^a  

^a Workers' Hospital   (China)

^b Hebei Union University   (China)

Author keywords

Brain metastatic cancers; Chemotherapy; Prognosis; Radiation therapy; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BRAIN; BRAIN TUMOR; BREAST TUMOR; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; MALE; MENINGIOMA; METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN; BRAIN NEOPLASMS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MENINGEAL NEOPLASMS; MIDDLE AGED; PROGNOSIS; SURVIVAL;

EID: 84877684467     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.2.923     Document Type: Article

References (20)

1. Abd-El-Barr MM, Rahman M, Rao G (2011). Investigational therapies for brain metastases. Neurosurg Clin N Am, 22, 87-96.
2. Bradley KA, Mehta MP (2004). Management of brain metastases. Semin Oncol, 31, 693-701.
3. Butowski N (2011). Medical management of brain metastases. Neurosurg Clin N Am, 22, 27-36.
4. De Angelis LM (2001). Brain Tumors. N Engl J Med, 344, 114-23.
5. Fabi A, Felici A, Metro G, et al (2011). Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center. J Exp Clin Cancer Res, 30, 10.
6. Gaspar L, Scott C, Rotman M, et al (1997). Recursive partitioning analsis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys, 37, 745-51.
7. Gavrilovic IT, Posner JB (2005). Brain metastases: epidemiology and pathophysiology. J Neurooncol, 75, 5-14.
8. Lagerwaard FJ, Levendag PC, Nowak PJ, et al (1999). Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys, 43, 795-803.
9. Lee DH, Han JY, Kim HT, et al (2008). Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first: result of a randomized pilot study. Cancer, 113, 143-9.
10. Matsunaga S, Shuto T, Suenaga J, Inomori S, Fujino H (2010). Gamma knife radiosurgery for central neurocytomas. Neurol Med Chir (Tokyo), 50, 107-13.
11. Mehta RC, Pike GB, Haros SP, Enzmann DR (1995). Central nervous system tumor, infection, and infarction, detection with gadolinium-enhanced magnetization transfer MR imaging. Radiology, 195, 41-6.
12. Meyers CA, Smith JA, Bezjak A, et al (2004). Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol, 22, 157-65.
13. Moscetti L, Nelli F, Felici A, et al (2007). Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology. Cancer, 109, 274-81.
14. Neuhaus T, Ko Y, Muller RP, et al (2009). A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer. Br J Cancer, 100, 291-7.
15. Newton HB (1999). Neurological complications of systemic cancer. Am Fam Phys, 59, 878-86.
16. Pardridge WM (2005). The blood-brain barrier: bottleneck in brain drug development. NeuroRx, 2, 3-14.
17. Patchell RA (2003). The management of brain metastases. Cancer Treat Rev, 29, 533-40.
18. Rades D, Pluemer A, Veninga T, Dunst J, Schild SE (2007). A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Cancer, 110, 1551-9.
19. Rahmathulla G, Toms SA, Weil RJ (2012). The Molecular Biology of Brain Metastasis. J Oncol, 2012, 16.
20. Sundstrom JT, Minn H, Lertola KK, Nordman E (1998). Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Ann Med, 30, 296-9.